The era of growth stocks getting a free pass on profitability appears to be largely over. Growth has slowed for many pandemic highfliers, bringing the bottom line into focus for investors. The ...

Since the start of the year, Ocugen (NASDAQ: OCGN) has been on fire. The biotech's shares have gained an eye-popping 122%, far surpassing the performance of small-cap growth stocks this year. (See the ...

The market is quiet but not at peace. Stocks have been churning in a narrow channel on low volume for weeks, the S&P 500 about flat on Friday, flat for the week and barely changed this month. With ...

Millions of ordinary investors rode Facebook on the way up, whether they fully realized it or not. Now, they’d better brace for the ride down. The stomach-churning collapse of Facebook parent Meta ...

U.S. stocks are churning between gains and losses on Wednesday amid uncertainty about how many more of the cuts to interest rates that Wall Street loves are on the way. 24/7 Wall St. Millionaire ...

Asana, Inc. is downgraded to Sell due to deteriorating fundamentals, persistent churn & lack of compelling growth catalysts.

Forget bulls and bears: Call it a duck market. That might be going a bit far, but Mark Hackett, chief market strategist at Nationwide, argues in a Monday note that the market's behavior right now is ...

Stocks, bonds and the dollar saw small moves at the start of a busy week for major central banks, whose rate decisions will set the tone for global markets for the rest of the year. The S&P 500 closed ...

NEW YORK (AP) — U.S. stocks are churning between gains and losses on Wednesday amid uncertainty about how many more of the cuts to interest rates that Wall Street loves are on the way. The S&P 500 ...